Consistent with our findings, previous reports showed that plasma GlcSph was increased in FTD‐GRN mutation carriers, but not in other symptomatic genetic mutation groups or non‐carriers.15, 17, 18. The gene discussed is GRN; the disease is frontotemporal dementia.